7 Clinical Trials for Various Conditions
The purpose of this clinical trial is to evaluate the dermal safety of Bemotrizinol (6%).
to determine the ability of the test article to cause irritation to the skin of humans under controlled patch test conditions
To assess the safety and tolerability for the extended wear of an experimental air-activated self adhesive patch.
A disposable, air-activated, adhesive backed heat patch is being developed to provide temporary relief from minor muscular ache and joint pains associated with overexertion strains and sprains as well as minor pain associated with arthritis. The aim of the study is to determine the safety and tolerability of the patch during normal wear conditions.
A disposable, air-activated, adhesive backed heat patch is being evaluated. Study terminated -O subjects.
The purpose of the study is to determine the irritation potential of repeat applications of abametapir lotion on normal skin.
This study is conducted to assess the potential of topically-applied GSK2894512 cream at 3 concentrations (0.5%, 1%, and 2%) to induce skin irritation at the site of application in healthy subjects. Results from this study will be considered when selecting the concentration(s) of GSK2894512 to evaluate in the Phase II and Phase III clinical safety and efficacy studies. Approximately 40 subjects will be enrolled in order to have at least 30 evaluable subjects complete the study. The total duration of subject participation may be up to 50 days.